CN116114796A - Stress protective agent and preparation method and application thereof - Google Patents
Stress protective agent and preparation method and application thereof Download PDFInfo
- Publication number
- CN116114796A CN116114796A CN202211342555.5A CN202211342555A CN116114796A CN 116114796 A CN116114796 A CN 116114796A CN 202211342555 A CN202211342555 A CN 202211342555A CN 116114796 A CN116114796 A CN 116114796A
- Authority
- CN
- China
- Prior art keywords
- stress
- protectant
- fish
- stress protectant
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003223 protective agent Substances 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 241000251468 Actinopterygii Species 0.000 claims abstract description 47
- 238000000034 method Methods 0.000 claims abstract description 28
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims abstract description 20
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims abstract description 20
- 235000021283 resveratrol Nutrition 0.000 claims abstract description 20
- 229940016667 resveratrol Drugs 0.000 claims abstract description 20
- FZAQROFXYZPAKI-UHFFFAOYSA-N anthracene-2-sulfonyl chloride Chemical compound C1=CC=CC2=CC3=CC(S(=O)(=O)Cl)=CC=C3C=C21 FZAQROFXYZPAKI-UHFFFAOYSA-N 0.000 claims abstract description 18
- 238000003756 stirring Methods 0.000 claims description 35
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 32
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 32
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 238000002156 mixing Methods 0.000 claims description 23
- 238000009210 therapy by ultrasound Methods 0.000 claims description 22
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 18
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 17
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 claims description 17
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 claims description 17
- 235000021323 fish oil Nutrition 0.000 claims description 17
- 229940083466 soybean lecithin Drugs 0.000 claims description 17
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 16
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 16
- 235000019136 lipoic acid Nutrition 0.000 claims description 16
- 239000012071 phase Substances 0.000 claims description 16
- 229960003080 taurine Drugs 0.000 claims description 16
- 229960002663 thioctic acid Drugs 0.000 claims description 16
- 229930006000 Sucrose Natural products 0.000 claims description 15
- 239000000839 emulsion Substances 0.000 claims description 15
- 239000005720 sucrose Substances 0.000 claims description 15
- -1 sucrose ester Chemical class 0.000 claims description 15
- 238000002791 soaking Methods 0.000 claims description 14
- 235000019198 oils Nutrition 0.000 claims description 13
- 239000008346 aqueous phase Substances 0.000 claims description 10
- 108010024636 Glutathione Proteins 0.000 claims description 9
- 239000005515 coenzyme Substances 0.000 claims description 9
- 229960003180 glutathione Drugs 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 8
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 8
- 229960001456 adenosine triphosphate Drugs 0.000 claims description 6
- 238000006213 oxygenation reaction Methods 0.000 claims description 4
- 108010016626 Dipeptides Proteins 0.000 claims description 3
- UGJBHEZMOKVTIM-UHFFFAOYSA-N N-formylglycine Chemical compound OC(=O)CNC=O UGJBHEZMOKVTIM-UHFFFAOYSA-N 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 5
- 210000003470 mitochondria Anatomy 0.000 abstract description 5
- 230000006378 damage Effects 0.000 abstract description 4
- 208000035240 Disease Resistance Diseases 0.000 abstract description 3
- 230000007613 environmental effect Effects 0.000 abstract description 3
- 230000001603 reducing effect Effects 0.000 abstract description 3
- 230000009471 action Effects 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000007547 defect Effects 0.000 abstract description 2
- 231100000956 nontoxicity Toxicity 0.000 abstract description 2
- 230000008439 repair process Effects 0.000 abstract description 2
- 230000008685 targeting Effects 0.000 abstract description 2
- 238000009360 aquaculture Methods 0.000 abstract 1
- 244000144974 aquaculture Species 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 239000013065 commercial product Substances 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 230000004083 survival effect Effects 0.000 description 7
- 230000002180 anti-stress Effects 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000003938 response to stress Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000003760 magnetic stirring Methods 0.000 description 2
- 230000002438 mitochondrial effect Effects 0.000 description 2
- 210000000607 neurosecretory system Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- PNMUAGGSDZXTHX-BYPYZUCNSA-N Gly-Gln Chemical compound NCC(=O)N[C@H](C(O)=O)CCC(N)=O PNMUAGGSDZXTHX-BYPYZUCNSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 241001648835 Polygonum cuspidatum Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 108010010147 glycylglutamine Proteins 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000006677 mitochondrial metabolism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
- A01K61/10—Culture of aquatic animals of fish
- A01K61/13—Prevention or treatment of fish diseases
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
- A23K20/126—Lactones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Environmental Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Insects & Arthropods (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Immunology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention provides a stress protective agent, which belongs to the technical field of aquaculture, and is prepared by compounding resveratrol, beta-nicotinamide mononucleotide and other components, and has stronger targeting property, shorter action time and oxidation resistance and can strengthen the repair capability of damaged mitochondria. The stress protectant can improve the stress resistance and disease resistance of fishes, and has the effects of strengthening the physique of the fishes and reducing the death rate. The invention also provides a preparation method and application of the stress protectant, and the application method can overcome the defect of single application method of the traditional stress protectant, and has the advantages of no toxicity, no harm and environmental protection.
Description
Technical Field
The invention belongs to the field of animal protection, and particularly relates to a stress protective agent and a preparation method and application thereof.
Background
The stress response of fish is a non-specific physiological response generated by ultra-long stimulation (stressor) of fish body to various environmental factors. Too strong or too long stress reaction can cause harm to organisms, so that the growth and development are slow, the reproductive capacity is reduced, the immune function is reduced, the morbidity and mortality are improved, and the like. The stress response of fish is related to various factors, such as farms, nutrition, transportation, diseases, crowded cultivation, manual operation and the like, so that the fish is usually dead in batches, most of injured fish is difficult to recover health, the resulting body wound is difficult to heal, the price of the fish in a pond is reduced, and huge economic loss is brought to the cultivation industry.
Fish stress generally occurs at three levels, namely, at the neuroendocrine system level, at the tissue and organ level, and at the individual and population level. Primary stress is a response at the level of the nervous and endocrine systems of animals such as fish, and is mainly manifested by a significant increase in plasma epinephrine or norepinephrine levels and a significant increase in plasma cortisol levels. Secondary stress is a change in various tissues and organs of the respiratory system, cardiovascular system, immune system, etc. caused by the primary reaction. Tertiary stress refers to changes in individual or population levels, such as changes in growth rate, disease resistance, reproductive capacity, and behavior, that result from secondary stress. Thus, anti-stress agents should begin with the three aspects above to eliminate stress-induced neuroendocrine system disorders and tissue and organ damage, reducing or eliminating individual and population level changes.
Currently, commercial anti-stress agents mainly comprise vitamins and electrolytes (vitamin B2, C, E, K and the like), and most of the formulations of the anti-stress agents come from animal studies, and have poor or no effects. Therefore, it is necessary to develop a stress protectant with obvious anti-stress effect and capable of obviously improving the survival rate of fish.
Disclosure of Invention
Therefore, the invention aims to provide a stress protective agent, a preparation method and application thereof, and aims to achieve the purposes of improving the physical fitness of fishes and reducing the death rate by adopting a high-efficiency antioxidant to target and regulate mitochondrial energy metabolism so as to reduce or eliminate a series of stress signals caused by free radicals and assisting with substances for promoting energy generation, reconstructing the energy metabolism of fishes, improving the stress resistance and disease resistance of the fishes.
In order to achieve the above purpose, the present invention provides the following technical solutions:
the stress protective agent comprises the following raw materials in percentage by mass: resveratrol 0.04-0.08%, beta-nicotinamide mononucleotide 0.08-0.2%, alpha-lipoic acid 0.05-0.15%, coenzyme Q0.1-0.4%, taurine 0.6-2.0%, gamma-aminobutyric acid 0.3-1.0%, glutathione 0.5-1.0%, soybean lecithin 0.5-1.2%, sucrose ester 0.5-2%, adenosine triphosphate 0.2-0.8%, fish oil 10-20% and the balance of water.
Preferably, the stress protectant comprises the following raw materials in percentage by mass: resveratrol 0.05-0.07%, beta-nicotinamide mononucleotide 0.09-0.15%, alpha-lipoic acid 0.07-0.13%, coenzyme Q0.2-0.3%, taurine 1.0-1.5%, gamma-aminobutyric acid 0.4-0.8%, glutathione 0.6-0.8%, soybean lecithin 0.7-1.1%, sucrose ester 0.8-1.6%, adenosine triphosphate 0.4-0.6%, fish oil 12-16% and the balance of water.
The invention also provides a preparation method of the stress protectant, which comprises the following steps:
(1) Mixing resveratrol, fish oil, soybean lecithin and coenzyme Q, and performing ultrasonic treatment to obtain oil phase emulsion;
(2) Mixing beta-nicotinamide mononucleotide, alpha-lipoic acid, taurine, gamma-aminobutyric acid, adenosine triphosphate, glycal dipeptide and sucrose ester with water to prepare an aqueous phase solution;
(3) And mixing the oil phase emulsion and the aqueous phase solution to obtain the stress protectant.
Preferably, stirring is carried out in the mixing process in the step (1), the rotating speed of stirring is 200-600r/min, and the stirring time is 20-60min;
further, the stirring is magnetic stirring;
preferably, the temperature of the ultrasonic treatment in the step (1) is 35-42 ℃, the power of the ultrasonic treatment is 300-500w, and the time of the ultrasonic treatment is 20-60min;
preferably, the stress protectant prepared in the step (3) is subjected to cold storage, and the temperature of the cold storage is 4-8 ℃.
The invention also provides application of the stress protectant in preventing fish stress reaction.
Preferably, the application method of the stress protectant in application comprises the following steps: mixing and feeding the feed and the stress protectant according to the mass ratio of 25-100:1; during feeding, 1000-1500 fish are fed per 50-100g of stress protectant; the mass of the cultured fish is 150-250 g/tail;
furthermore, the mixture can be fed after being mixed without obvious solution accumulation on the surface of the mixture.
Preferably, the application method of the stress protectant in application comprises the following steps: mixing the stress protectant with water according to the mass ratio of 1:150-200, soaking fish body for 15-25min, and simultaneously carrying out oxygenation treatment; soaking 400-600 tail fishes according to 50-150g of stress protectant during soaking; the fish has a mass of 150-250 g/tail, and the soaking times are 2-3 times.
Compared with the prior art, the invention has the following beneficial effects:
(1) The reagent adopted by the invention is not an anti-stress reagent taking antioxidants such as vitamin C, E as main components, but takes components which can act on mitochondria in a targeting way as main components, such as resveratrol, beta-nicotinamide mononucleotide and the like.
(2) Compared with the traditional anti-stress concept, the invention provides raw materials and energy for the normal functions of cells by adding various mitochondrial metabolism intermediates such as adenosine triphosphate, glutathione and the like, improves the antioxidant enzyme activity of the cells, and ensures that the cells participate in the repair process of mitochondria, thereby achieving the effect of relieving stress response in multiple aspects.
(3) The invention provides two different using methods of the stress protectant in application, namely a feed adding method and an acute soaking method, and the using method overcomes the defect of single using method of the stress protectant and has the advantages of no toxicity, no harm and environmental protection.
(4) The invention adopts a simple and efficient processing method, and utilizes a proper carrier to organically combine the main components together, thereby improving the absorption rate of the organism to the effective components; and by establishing modes of feed addition, acute soaking and the like, the use means of the stress protectant is enlarged, the maximum protection of the fish body under various extreme environments or operation conditions is realized, and the death and injury of the fish are reduced.
(5) Aiming at the stress reaction of aquatic animals caused by the operations such as transportation, pond moving and the like or the reasons such as too low feed fish meal, extreme climate and the like, the method starts from mitochondrial tissues which are mainly oxidized and powered, and the damaged mitochondria are protected or repaired in a targeted manner by reasonably matching with several reagents such as resveratrol, so that the normal functional state of the damaged mitochondria is promoted, the stress resistance of the aquatic animals is improved, the death rate is reduced, and the survival rate in the pond moving, transportation, fishing and high-vegetable-protein feed feeding process is improved.
Detailed Description
The invention provides a stress protective agent which comprises the following raw materials in percentage by mass: resveratrol 0.04-0.08%, beta-nicotinamide mononucleotide 0.08-0.2%, alpha-lipoic acid 0.05-0.15%, coenzyme Q0.1-0.4%, taurine 0.6-2.0%, gamma-aminobutyric acid 0.3-1.0%, glutathione 0.5-1.0%, soybean lecithin 0.5-1.2%, sucrose ester 0.5-2%, adenosine triphosphate 0.2-0.8%, fish oil 10-20% and the balance of water.
In the invention, the stress protectant comprises resveratrol 0.04-0.08%, preferably 0.05-0.07%, and more preferably 0.06%; the resveratrol is preferably polygonum cuspidatum extract, and the purity is more than or equal to 98%.
In the present invention, the stress protectant comprises 0.08-0.2%, preferably 0.09-0.15%, and more preferably 0.10% of beta-nicotinamide mononucleotide; the beta-nicotinamide mononucleotide is a commercial product, and the purity is more than or equal to 99 percent.
In the present invention, the stress protectant comprises 0.05-0.15%, preferably 0.07-0.13%, and more preferably 0.10% of alpha-lipoic acid; the alpha-lipoic acid is a commercial product, and the purity is more than or equal to 99 percent.
In the present invention, the stress protectant comprises coenzyme Q0.1-0.4%, preferably 0.2-0.3%, and more preferably 0.25%; the coenzyme Q is a commercial product, and the purity is more than or equal to 98 percent.
In the present invention, the stress protectant comprises taurine 0.6-2.0%, preferably 1.0-1.5%, and more preferably 1.3%; the taurine is a commercial product, and the purity is more than or equal to 98 percent.
In the present invention, the stress protectant comprises 0.3-1.0%, preferably 0.4-0.8%, and more preferably 0.5% of gamma-aminobutyric acid; the gamma-aminobutyric acid is a commercial product, and the purity is more than or equal to 98%.
In the present invention, the stress protectant comprises 0.5-1.0%, preferably 0.6-0.8%, and more preferably 0.7% of a glycylglutidine; the glycylglutamine is a commercial product, and the purity is more than or equal to 99 percent.
In the present invention, the stress protectant comprises soybean lecithin 0.5-1.2%, preferably 0.7-1.1%, and more preferably 1.0%; the soybean lecithin is a commercial product, and the purity is more than or equal to 99%.
In the present invention, the stress protectant comprises sucrose esters 0.5-2%, preferably 0.8-1.6%, and more preferably 1.2%; the sucrose ester is a commercial product, and the purity is more than or equal to 99 percent.
In the present invention, the stress protectant comprises adenosine triphosphate 0.2-0.8%, preferably 0.4-0.6%, and more preferably 0.5%; the adenosine triphosphate is a commercial product, and the purity is more than or equal to 99%.
In the invention, the stress protectant comprises 10-20%, preferably 12-16%, and more preferably 14% of fish oil; the fish oil is a commercial product, and the purity is more than or equal to 99 percent.
The invention also provides a preparation method of the stress protectant, which comprises the following steps:
(1) Mixing resveratrol, fish oil, soybean lecithin and coenzyme Q, and performing ultrasonic treatment to obtain oil phase emulsion;
(2) Mixing beta-nicotinamide mononucleotide, alpha-lipoic acid, taurine, gamma-aminobutyric acid, adenosine triphosphate, glycal dipeptide and sucrose ester with water to prepare an aqueous phase solution;
(3) And mixing the oil phase emulsion and the aqueous phase solution to obtain the stress protectant.
In the invention, resveratrol, fish oil, soybean lecithin and coenzyme Q are mixed; stirring is carried out in the mixing process, the rotating speed of stirring is 200-600r/min, and the stirring time is 20-60min; further preferably, the stirring is magnetic stirring, the rotating speed of the stirring is 300-500r/min, and the stirring time is 30-50min; still more preferably, the stirring speed is 400r/min, and the stirring time is 40min; the invention carries out ultrasonic treatment after stirring, wherein the temperature of the ultrasonic treatment is 35-42 ℃, the power of the ultrasonic treatment is 300-500w, and the time of the ultrasonic treatment is 20-60min; further preferably, the temperature of the ultrasonic treatment is 37-40 ℃, the power of the ultrasonic treatment is 350-450w, and the time of the ultrasonic treatment is 30-50min; still more preferably, the temperature of the ultrasonic treatment is 38 ℃, the power of the ultrasonic treatment is 400w, and the time of the ultrasonic treatment is 40min;
in the invention, the oil phase emulsion and the aqueous phase solution are mixed to prepare the stress protectant; the stirring treatment is preferably carried out during the mixing, the rotating speed of stirring is 200-600r/min, and the stirring time is 20-60min; further preferably, the stirring speed is 300-500r/min, and the stirring time is 30-50min; still more preferably, the stirring speed is 400r/min and the stirring time is 40min. In the invention, the stress protectant is preferably refrigerated and preserved, and the temperature of the refrigerated and preserved is 4-8 ℃; further preferably, the temperature of the refrigerated storage is 5-7 ℃; still more preferably, the temperature of the refrigerated storage is 6 ℃.
The invention also provides application of the stress protectant in preventing fish stress reaction.
In the invention, the using method of the stress protectant in application comprises a feed adding method: mixing and feeding the feed and the stress protectant according to the mass ratio of 25-100:1; during feeding, 1000-1500 fish are fed per 50-100g of stress protectant; the mass of the cultured fish is 150-250 g/tail. Furthermore, the mixture can be fed after being mixed without obvious solution accumulation on the surface of the mixture. In the present invention, the use time of the stress protectant is preferably 15-30 days before the stress reaction may occur, or long-term feeding.
In the invention, the application method of the stress protectant in application further comprises an acute soaking method: mixing the stress protectant with water according to the mass ratio of 1:150-200, soaking fish body for 15-25min, and simultaneously carrying out oxygenation treatment; soaking 400-600 tail fishes according to 50-150g of stress protectant during soaking; the fish has a mass of 150-250 g/tail, and the soaking times are 2-3 times.
The technical solutions provided by the present invention are described in detail below with reference to examples, but they should not be construed as limiting the scope of the present invention.
Example 1
The stress protective agent comprises the following raw material components in percentage by mass: resveratrol 0.06%, beta-nicotinamide mononucleotide 0.10%, alpha-lipoic acid 0.10%, coenzyme Q0.25%, taurine 1.3%, gamma-aminobutyric acid 0.5%, glutathione 0.7%, soybean lecithin 1.0%, sucrose ester 1.2%, adenosine triphosphate 0.5%, fish oil 14% and purified water 80.29%.
A method for preparing a stress protectant, comprising the following steps:
(1) Mixing resveratrol, fish oil, soybean lecithin and coenzyme Q according to mass content, stirring uniformly by a magnetic stirrer, regulating the rotating speed to 350r/min, stirring for 40min, adding into an ultrasonic stirrer, setting the power to 300w, setting the temperature to 40 ℃, and carrying out ultrasonic treatment for 30min to obtain the oil phase emulsion.
(2) Adding beta-nicotinamide mononucleotide, alpha-lipoic acid, taurine, gamma-aminobutyric acid, adenosine triphosphate, glycylglutidine and sucrose ester into purified water which is weighed according to mass fractions, and uniformly stirring to form a water phase solution.
(3) Mixing the oil phase emulsion and the aqueous phase solution, stirring for 40min at a rotation speed of 350r/min by a magnetic stirrer to obtain the stress protectant, and refrigerating at 6deg.C for use.
The application method of the stress protectant in the application of preventing the fish stress reaction comprises the following steps:
200g of stress protectant is taken and added into 30kg of water to soak fish bodies, and oxygenation treatment is carried out at the same time.
Example 2
The stress protective agent comprises the following raw material components in percentage by mass: resveratrol 0.04%, beta-nicotinamide mononucleotide 0.08%, alpha-lipoic acid 0.06%, coenzyme Q0.1%, taurine 0.6%, gamma-aminobutyric acid 0.4%, glutathione 0.5%, soybean lecithin 0.6%, sucrose ester 2.0%, adenosine triphosphate 0.2%, fish oil 20% and purified water 75.42%.
A method for preparing a stress protectant, comprising the following steps:
(1) Mixing resveratrol, fish oil, soybean lecithin and coenzyme Q according to mass content, stirring uniformly by a magnetic stirrer, regulating the rotating speed to 200r/min, stirring for 20min, adding into an ultrasonic stirrer, setting the power to 500w, and carrying out ultrasonic treatment for 20min at 35 ℃ to obtain the oil phase emulsion.
(2) Adding beta-nicotinamide mononucleotide, alpha-lipoic acid, taurine, gamma-aminobutyric acid, adenosine triphosphate, glycylglutidine and sucrose ester into purified water which is weighed according to mass fractions, and uniformly stirring to form a water phase solution.
(3) Mixing the oil phase emulsion and the aqueous phase solution, stirring at a rotation speed of 200r/min by a magnetic stirrer for 60min to obtain the stress protectant, and refrigerating at 4deg.C for use.
The application method of the stress protectant in the application of preventing the fish stress reaction comprises the following steps:
100g of stress protectant is taken and added into 5kg of feed, and the mixture is stirred and fed when no obvious solution is accumulated on the surface of the mixture.
Example 3
The stress protective agent comprises the following raw material components in percentage by mass: resveratrol 0.08%, beta-nicotinamide mononucleotide 0.2%, alpha-lipoic acid 0.15%, coenzyme Q0.4%, taurine 2.0%, gamma-aminobutyric acid 1.0%, glutathione 1.0%, soybean lecithin 1.2%, sucrose ester 0.5%, adenosine triphosphate 0.8%, fish oil 10% and purified water 82.67%.
A method for preparing a stress protectant, comprising the following steps:
(1) Mixing resveratrol, fish oil, soybean lecithin and coenzyme Q according to mass content, uniformly stirring by a magnetic stirrer, adjusting the rotating speed to 600r/min, stirring for 60min, putting into an ultrasonic stirrer, setting the power to 400w, setting the temperature to 42 ℃, and carrying out ultrasonic treatment for 60min to obtain an oil phase emulsion;
(2) Adding beta-nicotinamide mononucleotide, alpha-lipoic acid, taurine, gamma-aminobutyric acid, adenosine triphosphate, glycylglutidine and sucrose ester into purified water which is weighed according to mass fractions, and uniformly stirring to form a water phase solution.
(3) Mixing the oil phase emulsion and the aqueous phase solution, stirring for 20min at 600r/min of a magnetic stirrer to obtain the stress protectant, and refrigerating at 8deg.C.
Protection test one
The stress protectant prepared in the examples 1-3 of the invention is mixed with black to form pellet feed for feeding 10 months 2021.
The experiment is provided with a control group which is fed with pellet feed without adding a protective agent. And feeding the black in front of the pond moving of a certain culturing farm in the east camping for 11 months and 20 days, and fishing out the pond moving according to normal operation after feeding for one month, wherein the pond moving distance is about 10 km. The protection results are shown in table 1:
table 1 protection results
As a result, it is found that the survival rate of black of the fish stress protection emulsion can reach more than 95.96%, and the fish stress protection emulsion can quickly adapt to the new pond environment after the fish is transplanted, and no sequelae exists. The survival rate of the fish in the control group is only about 81.19-89.23%, and some fish cannot adapt to the new pond, and then the fish in the control group die about 4% in two or three days.
Protection test II
The stress protectant prepared in the invention example 1-2 is applied to the process of transporting weever from a smoke counter to east camping on 4 days of 2022, the water tanks in the transport vehicle are divided into two rows, the protectant is directly added into the water tank on one side for dipping, and the protectant is not added into the water tank on the other side. Pure oxygen is filled in the transportation process, and the transportation distance is 300 km or more. The protection results are shown in table 2:
table 2 protection results
After the transportation is finished, the survival rate of the weever on one side added with the protective agent is more than 95.84%, the state is good, and the new environment adaptability is strong. The survival rate of the weever on the side without the protective agent is only 79.28-84.08%, the fish body is blackened, and the action is slow. By contrast, the fish stress protective agent has remarkable protective effect on fish stress.
In conclusion, the stress protectant in the application can obviously relieve the stress response of fish and improve the survival rate of the fish when the stress response occurs.
The foregoing is merely a preferred embodiment of the present invention and it should be noted that modifications and adaptations to those skilled in the art may be made without departing from the principles of the present invention, which are intended to be comprehended within the scope of the present invention.
Claims (9)
1. The stress protective agent is characterized by comprising the following raw materials in percentage by mass: resveratrol 0.04-0.08%, beta-nicotinamide mononucleotide 0.08-0.2%, alpha-lipoic acid 0.05-0.15%, coenzyme Q0.1-0.4%, taurine 0.6-2.0%, gamma-aminobutyric acid 0.3-1.0%, glutathione 0.5-1.0%, soybean lecithin 0.5-1.2%, sucrose ester 0.5-2%, adenosine triphosphate 0.2-0.8%, fish oil 10-20% and the balance of water.
2. The stress protectant of claim 1, comprising the following raw materials in mass percent: resveratrol 0.05-0.07%, beta-nicotinamide mononucleotide 0.09-0.15%, alpha-lipoic acid 0.07-0.13%, coenzyme Q0.2-0.3%, taurine 1.0-1.5%, gamma-aminobutyric acid 0.4-0.8%, glutathione 0.6-0.8%, soybean lecithin 0.7-1.1%, sucrose ester 0.8-1.6%, adenosine triphosphate 0.4-0.6%, fish oil 12-16% and the balance of water.
3. A method of preparing the stress protectant of claim 1 or 2, comprising the steps of:
(1) Mixing resveratrol, fish oil, soybean lecithin and coenzyme Q, and performing ultrasonic treatment to obtain oil phase emulsion;
(2) Mixing beta-nicotinamide mononucleotide, alpha-lipoic acid, taurine, gamma-aminobutyric acid, adenosine triphosphate, glycal dipeptide and sucrose ester with water to prepare an aqueous phase solution;
(3) And mixing the oil phase emulsion and the aqueous phase solution to obtain the stress protectant.
4. The method according to claim 3, wherein the stirring is carried out during the mixing in the step (1), the stirring speed is 200-600r/min, and the stirring time is 20-60min.
5. A method according to claim 3, wherein the temperature of the ultrasonic treatment in step (1) is 35-42 ℃, the power of the ultrasonic treatment is 300-500w, and the time of the ultrasonic treatment is 20-60min.
6. The method according to claim 3, wherein the stress protectant obtained in step (3) is followed by cold storage at a temperature of 4-8deg.C.
7. Use of the stress protectant of claim 1 or 2 for preventing stress in fish.
8. The use according to claim 7, characterized in that the feed is mixed with the stress protectant in a mass ratio of 25-100:1, fed; during feeding, 1000-1500 fish are fed per 50-100g of stress protectant; the mass of the cultured fish is 150-250 g/tail.
9. The use according to claim 7, wherein the stress protectant is mixed with water in a mass ratio of 1:150-200, the fish body is soaked for 15-25min, and oxygenation is performed simultaneously; soaking 400-600 tail fishes according to 50-150g of stress protectant during soaking; the fish has a mass of 150-250 g/tail, and the soaking times are 2-3 times.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211342555.5A CN116114796B (en) | 2022-10-31 | 2022-10-31 | Stress protective agent and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211342555.5A CN116114796B (en) | 2022-10-31 | 2022-10-31 | Stress protective agent and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116114796A true CN116114796A (en) | 2023-05-16 |
CN116114796B CN116114796B (en) | 2024-04-02 |
Family
ID=86306902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211342555.5A Active CN116114796B (en) | 2022-10-31 | 2022-10-31 | Stress protective agent and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116114796B (en) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0898659A (en) * | 1994-09-30 | 1996-04-16 | Nippon Suisan Kaisha Ltd | Fish feed having improving effect on stress |
US20060257502A1 (en) * | 2005-05-11 | 2006-11-16 | Jiankang Liu | A combination of mitochondrial nutrients for relieving stress, preventing and improving stress-related disorders |
CN101357223A (en) * | 2008-08-30 | 2009-02-04 | 中国水产科学研究院淡水渔业研究中心 | Preparation method of anti-stress agent for fishing |
CN103110032A (en) * | 2013-03-20 | 2013-05-22 | 曾龙 | Pomfret compound feed with anti-stress and growth prompting function |
CN105030881A (en) * | 2015-07-28 | 2015-11-11 | 安徽科技学院 | Compound preparation for preventing beef cattle transport stress, and use method thereof |
CN106818545A (en) * | 2016-11-26 | 2017-06-13 | 安徽裕龙种植农民专业合作社 | A kind of method for breeding for improving the anti-ammonia nitrogen stress ability of black carp |
CN108157684A (en) * | 2018-01-25 | 2018-06-15 | 中国海洋大学 | A kind of feed addictive for improving Larimichthys crocea oxidation resistance and preparation method thereof |
CN112294802A (en) * | 2020-11-16 | 2021-02-02 | 佛山市顺德区活宝源生物科技有限公司 | Anti-stress preparation for reducing fry transportation loss and preparation process and use method thereof |
US20210077514A1 (en) * | 2019-09-16 | 2021-03-18 | Gautam Umesh Vora | Nutraceutical Composition for Improving Overall Health |
CN113832204A (en) * | 2021-09-22 | 2021-12-24 | 杭州吾尾科技有限公司 | NMN preparation method and NMN-containing dog and cat anti-aging health product formula |
CN114272273A (en) * | 2020-09-28 | 2022-04-05 | 曙光生命科技株式会社 | NMN-containing antioxidant composition and preparation method thereof |
-
2022
- 2022-10-31 CN CN202211342555.5A patent/CN116114796B/en active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0898659A (en) * | 1994-09-30 | 1996-04-16 | Nippon Suisan Kaisha Ltd | Fish feed having improving effect on stress |
US20060257502A1 (en) * | 2005-05-11 | 2006-11-16 | Jiankang Liu | A combination of mitochondrial nutrients for relieving stress, preventing and improving stress-related disorders |
CN101357223A (en) * | 2008-08-30 | 2009-02-04 | 中国水产科学研究院淡水渔业研究中心 | Preparation method of anti-stress agent for fishing |
CN103110032A (en) * | 2013-03-20 | 2013-05-22 | 曾龙 | Pomfret compound feed with anti-stress and growth prompting function |
CN105030881A (en) * | 2015-07-28 | 2015-11-11 | 安徽科技学院 | Compound preparation for preventing beef cattle transport stress, and use method thereof |
CN106818545A (en) * | 2016-11-26 | 2017-06-13 | 安徽裕龙种植农民专业合作社 | A kind of method for breeding for improving the anti-ammonia nitrogen stress ability of black carp |
CN108157684A (en) * | 2018-01-25 | 2018-06-15 | 中国海洋大学 | A kind of feed addictive for improving Larimichthys crocea oxidation resistance and preparation method thereof |
US20210077514A1 (en) * | 2019-09-16 | 2021-03-18 | Gautam Umesh Vora | Nutraceutical Composition for Improving Overall Health |
CN114272273A (en) * | 2020-09-28 | 2022-04-05 | 曙光生命科技株式会社 | NMN-containing antioxidant composition and preparation method thereof |
CN112294802A (en) * | 2020-11-16 | 2021-02-02 | 佛山市顺德区活宝源生物科技有限公司 | Anti-stress preparation for reducing fry transportation loss and preparation process and use method thereof |
CN113832204A (en) * | 2021-09-22 | 2021-12-24 | 杭州吾尾科技有限公司 | NMN preparation method and NMN-containing dog and cat anti-aging health product formula |
Also Published As
Publication number | Publication date |
---|---|
CN116114796B (en) | 2024-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jia et al. | Protein-sourced feedstuffs for aquatic animals in nutrition research and aquaculture | |
Wanapat et al. | Development of feeding systems and strategies of supplementation to enhance rumen fermentation and ruminant production in the tropics | |
CN102058625B (en) | High-efficient anti-stress agent for aquaculture | |
CN102919521A (en) | Vegetable feed additives for improving meat quality, pre-mix feed and formulated feed | |
CN110742211A (en) | Grouper feed accelerant and using method thereof | |
CN112262917A (en) | Preparation method of high-viable bacteria fermented feed | |
EP3378328B1 (en) | Use of animal nutrition fortifying agent | |
CN110604234A (en) | Application of Chlorella sorokiniana in functional feed for improving health condition of fishes | |
CN107149057A (en) | A kind of efficient fish mixed feed with anti-oxidation function | |
CN103535526B (en) | Feed additive for improving fat utilization rate | |
US20110046224A1 (en) | Methods to accelerate muscle development, decrease fat deposits, and enhance feeding efficiency in pigs | |
CN116114796B (en) | Stress protective agent and preparation method and application thereof | |
CN113273651A (en) | Longsnout catfish feed capable of improving fat utilization rate | |
Honcharova et al. | Physiological and biochemical aspects of the carp organism in conditions of increasing their viability when stocking water bodies. | |
Kromann et al. | Energy metabolism in sheep as influenced by interactions among the ration's energy content, physical form and buffers | |
Komlatsky et al. | Eco-friendly ways to feed pigs without antibiotics | |
CN114938830A (en) | Feed additive for improving lean meat percentage of livestock and poultry based on amino acid and preparation method and application thereof | |
CN104719677B (en) | A kind of sturgeon mixed feed that rubber seedcake utilization rate is improved using yolk powder | |
Abd Al-Qaisy et al. | Effect of Adding Taurine on Gene Expression of GPX1 and ACACA Genes of Broiler Chickens Raised at Different Temperatures | |
CN105724781A (en) | Feed composition and application thereof to preparation of animal feed additive | |
CN101597237B (en) | Iron (II)-threonine and preparation method and application thereof | |
CN110477218A (en) | A kind of nutrition prescription preventing the Yellow River carp hemorrhage and preparation method | |
AU2021101885A4 (en) | Feed additive for improving meat quality of fattening pigs | |
CN109874705B (en) | Breeding method capable of effectively improving rainbow trout meat quality | |
Honcharova et al. | Adaptive solutions in aquaculture under the influence оf transformation of abiotic and biotic factors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |